<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Coleção:</title>
  <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/11049" />
  <subtitle />
  <id>http://repositorio.ufc.br/handle/riufc/11049</id>
  <updated>2026-06-14T13:27:58Z</updated>
  <dc:date>2026-06-14T13:27:58Z</dc:date>
  <entry>
    <title>Avaliação antimicrobiana e prevenção de lesões de cárie dentária com o uso do dentifrício de própolis vermelha brasileira: estudo  laboratorial e ensaio clínico randomizado</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/86009" />
    <author>
      <name>Chagas, Francineudo Oliveira</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/86009</id>
    <updated>2026-04-24T17:50:35Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Título: Avaliação antimicrobiana e prevenção de lesões de cárie dentária com o uso do dentifrício de própolis vermelha brasileira: estudo  laboratorial e ensaio clínico randomizado
Autor(es): Chagas, Francineudo Oliveira
Abstract: The development of dental formulations with propolis is a growing reality in the pharmaceutical industry, especially for diseases related to biofilm. This study evaluated in vitro and in vivo the use of fluoridated toothpaste containing 1% Brazilian red propolis (BRP) in controlling marginal bleeding and preventing caries lesions in orthodontic patients. In the in vitro phase, the antimicrobial activity of the BRP extract and the toothpaste incorporating the extract was evaluated against Streptococcus mutans ATCC UA159. The clinical phase consisted of a randomized, double-blind, controlled, longitudinal clinical trial involving 60 orthodontic patients aged 12 to 18 years, followed for a period of six months. Participants were divided into two groups: a test group (toothpaste with BRP + 1500 ppm fluoride) and a control group (toothpaste with 1500 ppm fluoride). Clinical assessments were performed at baseline, and at 2, 4, and 6 months, using the ICDAS II criteria for detecting carious lesions and the gingival bleeding index. Statistical analyses were performed using the Kruskal-Wallis and Mann-Whitney tests, and significance adjustment was performed using the Bonferroni method, considering a significance level of 5%. The results demonstrated that both the PVB extract and the toothpaste containing PVB showed significant antimicrobial activity, with a reduction in bacterial viability up to a concentration of 0.3906 µg/mL (p &lt; 0.05). The minimum bactericidal effect (MBC) was observed at a concentration of 1.5625 µg/mL for both groups. No statistically significant differences were observed between the PVB extract and the toothpaste formulated with the extract (p &gt; 0.05), indicating that the incorporation process did not compromise the antimicrobial activity. The commercial toothpaste Parodontax® showed antimicrobial activity in all dilutions tested, with MBC equivalent to that of PVB (1.5625 µg/mL), showing greater overall antimicrobial potency (p &lt; 0.05). These findings confirm the ability of PVB to directly interfere with the viability of cariogenic microorganisms. In the clinical phase, the results demonstrated that the group using the toothpaste containing PVB maintained a higher proportion of healthy surfaces (ICDAS II = 0) throughout the follow-up, while the control group showed significant progression to initial lesions (ICDAS II = 1), with a statistically significant difference between the groups (p ≤ 0.05). Regarding gingival condition, a significant reduction in the gingival bleeding index was observed in the PVB group at 4 and 6 months of follow-up (p ≤ 0.05), contrasting with the progressive increase observed in the control group. The in vitro and clinical results demonstrate that the fluoridated toothpaste containing PVB has antimicrobial activity, associated with significant clinical benefits in the prevention of initial caries and in the control of gingival inflammation in orthodontic patients. The combination of PVB with fluoride proved to be effective, safe, and biocompatible, without compromising traditional anti-caries action, consolidating this toothpaste as a promising preventive strategy for managing dental biofilm in at-risk populations.
Tipo: Tese</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Tratamento com gel fitoterápico à base de Myracrodruon urundeuva na cicatrização de úlceras orais por Cisplastina in vitro</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/84064" />
    <author>
      <name>Vasconcelos, Raquel Bastos</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/84064</id>
    <updated>2026-01-05T15:47:40Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Título: Tratamento com gel fitoterápico à base de Myracrodruon urundeuva na cicatrização de úlceras orais por Cisplastina in vitro
Autor(es): Vasconcelos, Raquel Bastos
Abstract: The Brazilian pepper tree (Myracrodruon urundeuva Allemão - Mu), Anacardiaceae, is a species from northeastern Brazil widely used in traditional medicine due to its property’s therapeutics recognized, as actions anti-inflammatory, antimicrobial and healing. These properties are mainly attributed to the presence of polyphenolic compounds such as tannins and chalcones dimeric. Despite of your use to be infused in the culture, studies that evaluate the toxicity of plant-derived formulations and their nociceptive and anti-inflammatory capacity, especially in orofacial models in vivo, do not yet present information considered in the literature. In this context, the present work has the general objective of evaluating the dental phytotherapeutic gel the base of Myracrodruon urundeuva German in oral mucositis, which is presented in four chapters: Chapter 1: Traditional uses, phytochemical studies and activities&#xD;
biological of Myracrodruon urundeuva (aroeira-do-sertão): a narrative review. This is an article with your methodology extensive on Mu, where it was realized that this is a remarkable plant of ethnopharmacological, technical-scientific and socioeconomic values; Chapter 2: From traditions to innovations: the pharmacochemical potential of aroeira-do-sertão (Myracrodroun) urundeuva German . It is an article that addresses Mu's technological and sustainable&#xD;
innovations, where the patent search took place between August and September 2024, with no time restrictions on the date of application or publication , thus allowing mapping the panorama of development technological related to this plant; Chapter 3: Preclinical evaluation of activity&#xD;
toxicological and nociceptive of gel of Myracrodruon urundeuva German for dental purposes in zebrafish ( danio rerio ) adult. Initially, preliminary pharmacognostic studies were carried out with the inner bark and gel preparation at 10% and 20%. Animal experiments were then performed using zebrafish to test toxicity and orofacial pain; the results demonstrated a&#xD;
satisfactory safety profile in zebrafish mucosa, causing no toxicity and demonstrating significant signs of nociceptive action, suggesting it could have analgesic properties. thus proving what the gel and effective in controlling nociception ; Chapter 4: Analysis of the efficacy and efficiency of Myracrodruon -based herbal gel urundeuva Allemão in the healing of oral ulcers in experiments with rats Wister , where it was observed that the 10% phytotherapeutic gel is effective in oral treatments, with healing potential, possible analgesic and antiulcer effect , in line with the trials with zebrafish, demonstrating promising results with predictability of its safety in oral mucositis.
Tipo: Tese</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Avaliação do potencial farmacoquímico da Dimorphandra mollis Benth. (fava- d’anta): do extrativismo sustentável ao desenvolvimento de fitoterápico</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/83321" />
    <author>
      <name>Silva, Willams Alves da</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/83321</id>
    <updated>2025-11-07T14:14:16Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Título: Avaliação do potencial farmacoquímico da Dimorphandra mollis Benth. (fava- d’anta): do extrativismo sustentável ao desenvolvimento de fitoterápico
Autor(es): Silva, Willams Alves da
Abstract: Introduction: Dimorphandra mollis Benth. is a native Brazilian plant, widely valued due to its high content of rutin, a flavonoid with antioxidant, anti-inflammatory, cardioprotective, and antidiabetic properties. Objective: To develop a herbal medicine from the hydroalcoholic extract of D. mollis pods for the treatment of atopic dermatitis (AD). Materials and methods: The bibliometric analysis included 122 publications collected from the Scopus and Web of Science databases, using the Bibliometrix, VOSviewer, Biblioshiny, Excel, and OriginPro software packages. Patent prospecting was performed in the USPTO, WIPO, EPO, and INPI databases, using terms related to the species and filtering by language and CPC classification. The botanical material was collected in Jardim (CE). The pods were dried, pulverized, and analyzed for particle size, moisture, and total ash. Preliminary phytochemical screening identified secondary metabolites, and extracts were obtained by fractional percolation with hydroalcoholic solvents under different conditions. Rutin and quercetin were quantified by High Performance Liquid Chromatography (HPLC). Analyses were performed using an Ultra Performance Liquid Chromatography (UPLC) system. n silico studies were performed with the isolated molecules to predict biological activity, cytotoxicity, antibacterial potential, pharmacokinetic and toxicological parameters, and skin permeation. In vivo tests were conducted with zebrafish (Danio rerio). The procedures were approved by CEUA-UECE, protocol no. 04009489/2023. Based on the fluid extract of D. mollis, a phytotherapeutic formulation was developed. The parameters evaluated included pH, spreadability, viscosity, density, optical microscopy, and centrifugation. Finally, the quantification of the active ingredients in the formulation was performed by CLAE, using methanol extraction, sonication, and centrifugation, with comparison to analytical standards. Results: Bibliometric analysis identified 122 publications on Dimorphandra between 1969 and 2023, with an annual growth of 2.6%, 3,592 citations, and international collaboration in 10.66% of the studies. The Journal of Ethnopharmacology was the most cited, and the article with the greatest impact had 157 citations. The patentometric analysis revealed 109 records, with 26 eligible patents (classes A23 and A61), mostly in WIPO (45%), highlighting Brazil's low participation in the international scenario. In the pharmacognostic study of D. mollis, the plant powder was classified as coarse (0.774 mm), with moisture content (9,67 ± 0,86) and ash content (1,0447 ± 0,0140%) within standards. Phytochemistry revealed a high concentration of flavonoids in the fruits, in addition to saponins, resins, tannins, triterpenes, alkaloids, and steroids. Extraction with 50% ethanol resulted in a better chromatographic profile and higher flavonoid content, with hot 50% ethanol extraction showing a better chromatographic profile (Rf = 0.37 for rutin and Rf = 0.67 for quercetin) and higher total flavonoid content. In addition, among the compounds detected by UPLC, hispidulin, syringetin, and protocatechuic acid stand out as the first report for the genus Dimorphandra. In silico analyses indicated anti-inflammatory, antioxidant, and vasoprotective potential for rutin and quercetin, with low cytotoxicity. In the in vivo model with zebrafish, the extract was non-toxic (LC50 &gt; 950 mg/mL), increased locomotion, and reduced edema, confirming antinociceptive and anti-inflammatory effects. The emulgel formulation showed stability for 60 days, maintaining pH, viscosity, spreadability, and concentration of markers under refrigeration and room temperature. In the oven, there was thermal degradation of flavonoids, highlighting the importance of temperature control to ensure the effectiveness of the formulation. Conclusion: The results validate the feasibility of using&#xD;
fava-d'anta as an active ingredient of bioactive plant origin in pharmaceutical and cosmetic formulations.
Tipo: Tese</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Estabilidade e cinética do fluoreto na cavidade oral após uso de dentifrício de própolis vermelha brasileira em pacientes ortodônticos: estudos in vitro e clínico</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/80810" />
    <author>
      <name>Azevedo, Arthur Almeida</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/80810</id>
    <updated>2025-05-12T18:24:14Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Título: Estabilidade e cinética do fluoreto na cavidade oral após uso de dentifrício de própolis vermelha brasileira em pacientes ortodônticos: estudos in vitro e clínico
Autor(es): Azevedo, Arthur Almeida
Abstract: The use of natural products in oral care formulations is something increasingly used by industries in their development. In this context, toothpastes are the most used products in oral care, standing out for their anti-caries activity due to fluoride and often with antimicrobial properties of molecules. This study aimed to evaluate the stability of a toothpaste developed with 1% Brazilian red propolis (BRP) extract and verify the kinetics of fluoride in saliva after use. The research was divided into two stages. The first is an in vitro study that aimed to evaluate the physicochemical characteristics of the aforementioned toothpaste over a period of one year. The physicochemical characterization of the BRP dentifrice was carried out and its stability was analyzed on the day of handling, 90, 180 and 365 days after storage. Tests included: macroscopic analysis and determination of pH and mass. The second was a randomized, crossover clinical study. Adolescent orthodontic patients were included in this study and were given a non-fluoridated toothpaste to use during a wash-out period three days before treatment. The intervention consisted of brushing with 1 g of toothpaste, then saliva was collected to analyze the fluoride concentration using a specific electrode immediately after brushing at different times (0–baseline, 15 minutes, 30 minutes, 1,2,4 and 6 hours). The results of the first stage showed that the odor and appearance demonstrated stability, exhibiting a characteristic odor of propolis and mild menthol, as well as the appearance of a standard dentifrice. The pH of the formulation showed small variations during measurements. The concentration of fluoride in saliva increased significantly after brushing with both dentifrices, reaching maximum concentration at 30 minutes for total fluoride (TF) and total soluble fluoride (FST) in the dentifrice incorporated with BRP, and at 15 minutes in the conventional dentifrice. No significant difference was observed in the concentrations of the types of fluoride analyzed between the two dentifrices (P&gt;0.05). The area under the curve showed no significant difference between TF(p=0.4426) and TSF(P=0.7109) of both dentifrices. Fluoride concentrations, measured in mgL-1, covered a range of 0.00 to 10.52 for the toothpaste incorporated with BRP and from 0.00 to 10.71 for the conventional fluoride toothpaste. No significant difference was observed between the two groups in relation to maximum concentrations of TF (P=0.0987) and TSF (P=0.9124). From the above, it was found that the pH of the dentifrice was suitable for this type of pharmaceutical form, as an acidic pH of the product could cause wear on the matrix and, as it is a calcium and fluoride dentifrice, it could favor the demineralization process. There was no difference between the toothpastes and, at the end of collection, the concentrations were already at values similar to the basal level.
Tipo: Tese</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

